JP2016520531A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016520531A5 JP2016520531A5 JP2016503332A JP2016503332A JP2016520531A5 JP 2016520531 A5 JP2016520531 A5 JP 2016520531A5 JP 2016503332 A JP2016503332 A JP 2016503332A JP 2016503332 A JP2016503332 A JP 2016503332A JP 2016520531 A5 JP2016520531 A5 JP 2016520531A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- scgb3a2
- recombinant human
- homodimer
- intact
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101000739178 Homo sapiens Secretoglobin family 3A member 2 Proteins 0.000 claims 6
- 102100037269 Secretoglobin family 3A member 2 Human genes 0.000 claims 3
- 102000058039 human SCGB3A2 Human genes 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 230000004927 fusion Effects 0.000 claims 2
- 239000000710 homodimer Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 1
- 101710096328 Phospholipase A2 Proteins 0.000 claims 1
- 102100026918 Phospholipase A2 Human genes 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000001155 isoelectric focusing Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/843,289 US20140274915A1 (en) | 2013-03-15 | 2013-03-15 | Methods of Use for Recombinant Human Secretoglobins |
| US13/843,289 | 2013-03-15 | ||
| PCT/US2014/030101 WO2014145357A2 (en) | 2013-03-15 | 2014-03-16 | Improved methods of use for recombinant human secretoglobins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016520531A JP2016520531A (ja) | 2016-07-14 |
| JP2016520531A5 true JP2016520531A5 (OSRAM) | 2017-04-27 |
| JP6513632B2 JP6513632B2 (ja) | 2019-05-15 |
Family
ID=51529893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503332A Active JP6513632B2 (ja) | 2013-03-15 | 2014-03-16 | 組換えヒトセクレトグロビンの改善された使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US20140274915A1 (OSRAM) |
| EP (1) | EP2968464B1 (OSRAM) |
| JP (1) | JP6513632B2 (OSRAM) |
| KR (1) | KR20160011621A (OSRAM) |
| CN (1) | CN105722524B (OSRAM) |
| AU (1) | AU2014233116A1 (OSRAM) |
| BR (1) | BR112015021265A2 (OSRAM) |
| CA (1) | CA2907395A1 (OSRAM) |
| ES (1) | ES2883933T3 (OSRAM) |
| IL (1) | IL241418A0 (OSRAM) |
| MX (1) | MX2015013091A (OSRAM) |
| RU (1) | RU2662665C2 (OSRAM) |
| SG (1) | SG11201507276UA (OSRAM) |
| UA (1) | UA118756C2 (OSRAM) |
| WO (1) | WO2014145357A2 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140274915A1 (en) * | 2013-03-15 | 2014-09-18 | Clarassance, Inc. | Methods of Use for Recombinant Human Secretoglobins |
| WO2016205430A1 (en) * | 2015-06-15 | 2016-12-22 | Therabron Therapeutics, Inc. | Recombinant human cc10 protein facilitates repair and protects against damage to the respiratory epithelium due to exposure to both cigarette and other smoke |
| WO2018178051A1 (en) * | 2017-03-28 | 2018-10-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Scgb1a1 polymorphism for the prediction and therapy or prevention of primary graft dysfunction |
| WO2019143934A1 (en) | 2018-01-19 | 2019-07-25 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-cancer activity of scbg3a2 and lps |
| JP2022509856A (ja) * | 2018-11-30 | 2022-01-24 | エーピーシー リサーチ アセッツ，エルエルシー | ヘパラン硫酸プロテオグリカンタンパク質との相互作用を介してグリコカリックスを保護するためのセクレトグロビンの組成物及び使用方法 |
| KR20200138684A (ko) * | 2020-11-17 | 2020-12-10 | 김유신 | 토양 파쇄기를 장착한 친환경 고온스팀 토양소독기 |
| WO2023212398A1 (en) * | 2022-04-29 | 2023-11-02 | Apc Research Assets Llc | Secretoglobins for suppression of antibody responses |
| CN119631983B (zh) * | 2024-12-30 | 2025-07-22 | 西南医科大学 | 一种心脏原发性肿瘤小鼠模型的构建方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040047857A1 (en) | 1997-05-28 | 2004-03-11 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20030008816A1 (en) | 1997-05-28 | 2003-01-09 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20060281681A1 (en) * | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
| AU5551299A (en) | 1998-08-13 | 2000-03-06 | Trustees Of The University Of Pennsylvania, The | Method of identifying proteins |
| US6953666B1 (en) | 1998-11-06 | 2005-10-11 | Emory University | Biomarkers for oxidative stress |
| WO2004101824A1 (ja) * | 2003-05-14 | 2004-11-25 | Shionogi & Co., Ltd. | 慢性閉塞性肺疾患の検出方法 |
| AU2004254600A1 (en) * | 2003-06-26 | 2005-01-13 | Lifesensors, Inc. | Methods and compositions for enhanced protein expression and purification |
| US7318936B2 (en) | 2003-11-14 | 2008-01-15 | Alza Corporation | Minimization of drug oxidation in drug irradiated excipients formulations |
| US20060275794A1 (en) * | 2005-03-07 | 2006-12-07 | Invitrogen Corporation | Collections of matched biological reagents and methods for identifying matched reagents |
| JP2007059191A (ja) | 2005-08-24 | 2007-03-08 | Kazuo Kono | 照明器具駆動回路 |
| WO2008039941A2 (en) * | 2006-09-27 | 2008-04-03 | The Government Of The Usa As Represented By The Secretary Of The Dpt. Of Health And Human Services | Scgb3a2 as a growth factor and anti-apoptotic agent |
| US20090004684A1 (en) | 2007-05-23 | 2009-01-01 | Claudia Susanne Maier | Compositions and Methods for Detection and Quantification of Protein Oxidation |
| EP2488205B1 (en) | 2009-10-15 | 2016-09-21 | Clarassance, Inc. | Recombinant human cc10 protein for treatment of influenza |
| RU2439569C1 (ru) * | 2010-11-12 | 2012-01-10 | Федеральное государственное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения и социального развития Российской Федерации | Способ прогнозирования бронхолегочной дисплазии у детей с врожденной пневмонией |
| US20140274915A1 (en) | 2013-03-15 | 2014-09-18 | Clarassance, Inc. | Methods of Use for Recombinant Human Secretoglobins |
-
2013
- 2013-03-15 US US13/843,289 patent/US20140274915A1/en not_active Abandoned
-
2014
- 2014-03-16 CN CN201480015596.0A patent/CN105722524B/zh not_active Expired - Fee Related
- 2014-03-16 AU AU2014233116A patent/AU2014233116A1/en not_active Abandoned
- 2014-03-16 EP EP14763146.9A patent/EP2968464B1/en active Active
- 2014-03-16 UA UAA201509797A patent/UA118756C2/uk unknown
- 2014-03-16 KR KR1020157029167A patent/KR20160011621A/ko not_active Ceased
- 2014-03-16 MX MX2015013091A patent/MX2015013091A/es active IP Right Grant
- 2014-03-16 CA CA2907395A patent/CA2907395A1/en not_active Abandoned
- 2014-03-16 RU RU2015144359A patent/RU2662665C2/ru active
- 2014-03-16 SG SG11201507276UA patent/SG11201507276UA/en unknown
- 2014-03-16 WO PCT/US2014/030101 patent/WO2014145357A2/en not_active Ceased
- 2014-03-16 ES ES14763146T patent/ES2883933T3/es active Active
- 2014-03-16 JP JP2016503332A patent/JP6513632B2/ja active Active
- 2014-03-16 BR BR112015021265A patent/BR112015021265A2/pt not_active IP Right Cessation
-
2015
- 2015-09-09 IL IL241418A patent/IL241418A0/en unknown
- 2015-10-12 US US14/880,908 patent/US9765127B2/en active Active
-
2017
- 2017-09-18 US US15/707,934 patent/US10556938B2/en active Active
-
2020
- 2020-02-07 US US16/785,221 patent/US11512121B2/en active Active
-
2022
- 2022-11-28 US US18/070,407 patent/US20240376162A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016520531A5 (OSRAM) | ||
| PH12020550205A1 (en) | IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE | |
| MX2023007211A (es) | Anticuerpos antimiostatina y metodos de uso. | |
| MX2020006117A (es) | Integracion dirigida de acidos nucleicos. | |
| PH12018501280A1 (en) | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use | |
| MX2021000030A (es) | Metodos y composiciones que utilizan polipeptidos variantes klotho. | |
| PE20190845A1 (es) | Metodos para determinar resistencia a terapia de receptor de androgeno | |
| AU2017263237A1 (en) | GDF15 fusion proteins and uses thereof | |
| MX2017006866A (es) | Pares de unión para producción de péptidos. | |
| PH12020550240A1 (en) | D-domain containing polypeptides and uses thereof | |
| WO2014202616A3 (en) | Rasamsonia gene and use thereof | |
| MX382929B (es) | Polipéptido heterodimerizado. | |
| EP3572093A8 (en) | Fgfr fusions | |
| MX2017010880A (es) | Variantes de polipéptidos para el clivaje de la toxina fusario, aditivo que contiene las mismas, uso de las mismas, y método para el clivaje de las toxinas fusario. | |
| PH12020550927A1 (en) | Therapeutic enzyme fusion protein having novel structure and use thereof | |
| MX2018011425A (es) | Construcciones de anticuerpos de adn y método para utilizarlas. | |
| PL393578A1 (pl) | Przeciwnowotworowe białko fuzyjne | |
| PH12020500054A1 (en) | Novel therapeutic enzyme fusion protein and use thereof | |
| WO2016130628A8 (en) | Griffithsin mutants | |
| WO2014170460A3 (en) | Method for the production of collagen proteins derived from marine sponges and an organism able to produce said proteins | |
| NZ724196A (en) | Uti fusion proteins | |
| JP2016519950A5 (OSRAM) | ||
| WO2018069947A8 (en) | Nucleotide sequence expressing an exosome-anchoring protein for use as vaccine | |
| MX2015009867A (es) | Mutantes del factor x. | |
| WO2018081350A8 (en) | SIGNAL POLYPEPTIDE FOR ENHANCED PROTEIN SECRETION |